Mark Kozloff to Peritoneal Neoplasms
This is a "connection" page, showing publications Mark Kozloff has written about Peritoneal Neoplasms.
Connection Strength
0.025
-
Phase II trial of bevacizumab plus gemcitabine in patients with advanced pancreatic cancer. J Clin Oncol. 2005 Nov 01; 23(31):8033-40.
Score: 0.015
-
Intracavitary bleomycin for the control of malignant effusions. J Surg Oncol. 1981; 16(3):273-7.
Score: 0.011